Cheaper drug for prostate cancer
Wockhardt Ltd. has launched its breakthrough 30 day release injectible form of prostate cancer drug, Leuprolide. Leuprolide is a drug of choice world wide for prostate cancer, a malignant growth
Wockhardt Ltd. has launched its breakthrough 30 day release injectible form of prostate cancer drug, Leuprolide. Leuprolide is a drug of choice world wide for prostate cancer, a malignant growth